Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Early Onset Alzheimer Disease: early-phase trial registry
3 of 4 indexed Early Onset Alzheimer Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Early Onset Alzheimer Disease: 4 US clinical trials tracked, 3 recruiting.
Early Onset Alzheimer Disease is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is xCures, running 1 of these trials.
Enrollment posture brief
Registry condition early-onset-alzheimer-disease
OPEN 3 | RECR 75% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Early Onset Alzheimer Disease lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Early Onset Alzheimer Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Early Onset Alzheimer Disease is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
xCures
NCT06539169
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Indiana University
NCT03507257
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
Alnylam Pharmaceuticals
NCT05231785
48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease
Mayo Clinic
NCT04002583
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Early Onset Alzheimer Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Early Onset Alzheimer Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Early Onset Alzheimer Disease page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Early Onset Alzheimer Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- xCures sponsors the most Early Onset Alzheimer Disease trials on record, review their full trial history before evaluating a specific study. See xCures's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Early Onset Alzheimer Disease condition card totals 4 registered trials; most-linked intervention Computer assisted ambulatory electroencephalogram; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.